BR0209327A - Composição para tratamento de constipação induzida por drogas - Google Patents

Composição para tratamento de constipação induzida por drogas

Info

Publication number
BR0209327A
BR0209327A BR0209327-8A BR0209327A BR0209327A BR 0209327 A BR0209327 A BR 0209327A BR 0209327 A BR0209327 A BR 0209327A BR 0209327 A BR0209327 A BR 0209327A
Authority
BR
Brazil
Prior art keywords
drug
composition
induced constipation
treatment
present
Prior art date
Application number
BR0209327-8A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23104042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0209327(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0209327A publication Critical patent/BR0209327A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO PARA TRATAMENTO DE CONSTIPAçãO INDUZIDA POR DROGAS". A presente invenção refere-se a uma composição para tratamento de constipação induzida por drogas, compreendendo um composto de 15-ceto-prostaglandina como ingrediente ativo. A composição da presente invenção apresenta uma forte ação antagonista contra a constipação induzida por drogas, sem que seja substancialmente perdido o efeito principal da droga.
BR0209327-8A 2001-05-02 2002-04-26 Composição para tratamento de constipação induzida por drogas BR0209327A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28772001P 2001-05-02 2001-05-02
PCT/JP2002/004223 WO2002089812A1 (en) 2001-05-02 2002-04-26 Composition for treating drug-induced constipation with 15-keto-prostaglandins

Publications (1)

Publication Number Publication Date
BR0209327A true BR0209327A (pt) 2004-07-20

Family

ID=23104042

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209327-8A BR0209327A (pt) 2001-05-02 2002-04-26 Composição para tratamento de constipação induzida por drogas

Country Status (19)

Country Link
US (1) US6982283B2 (pt)
EP (1) EP1392318B1 (pt)
JP (1) JP4332353B2 (pt)
KR (1) KR100886598B1 (pt)
CN (1) CN1522147B (pt)
AR (2) AR035237A1 (pt)
AT (1) ATE355067T1 (pt)
AU (1) AU2002251554B2 (pt)
BR (1) BR0209327A (pt)
CA (1) CA2444103C (pt)
DE (1) DE60218451T2 (pt)
DK (1) DK1392318T3 (pt)
ES (1) ES2282408T3 (pt)
MX (1) MXPA03010019A (pt)
NO (1) NO335143B1 (pt)
NZ (1) NZ529187A (pt)
PT (1) PT1392318E (pt)
TW (1) TWI302100B (pt)
WO (1) WO2002089812A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
CN1753680B (zh) * 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
TWI387454B (zh) * 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
MX2007010833A (es) * 2005-03-07 2009-02-17 Univ Chicago Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
CA2602812C (en) * 2005-04-12 2014-11-18 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
WO2009059307A1 (en) * 2007-11-01 2009-05-07 Washington University In St. Louis Compositions and methods for treating pruritus
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8957024B2 (en) 2011-07-27 2015-02-17 Washington University Composition and methods for reducing opioid-induced pruritus
KR20140052389A (ko) 2012-10-24 2014-05-07 주식회사 아리바이오 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물
US20140116916A1 (en) 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CN105777601A (zh) * 2014-12-26 2016-07-20 中国人民解放军第二军医大学 一种前列地尔衍生物及其药物制剂
CA3018589A1 (en) * 2016-03-29 2017-10-05 Colonaryconcepts Llc Formulations for treating constipation
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
DE3873007T2 (de) * 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW249226B (pt) 1990-04-04 1995-06-11 Aderk Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
NZ529406A (en) * 2001-05-18 2005-09-30 Sucampo Ag Halogenated prostaglandin derivatives for treating constipation and cleansing the gastrointestinal tract

Also Published As

Publication number Publication date
TWI302100B (en) 2008-10-21
DK1392318T3 (da) 2007-06-25
JP4332353B2 (ja) 2009-09-16
WO2002089812A1 (en) 2002-11-14
ATE355067T1 (de) 2006-03-15
KR100886598B1 (ko) 2009-03-05
PT1392318E (pt) 2007-05-31
US6982283B2 (en) 2006-01-03
KR20040008168A (ko) 2004-01-28
NO20034864L (no) 2003-12-23
AU2002251554B2 (en) 2007-05-24
CA2444103A1 (en) 2002-11-14
AR035237A1 (es) 2004-05-05
ES2282408T3 (es) 2007-10-16
US20030073746A1 (en) 2003-04-17
NO335143B1 (no) 2014-09-29
NO20034864D0 (no) 2003-10-31
MXPA03010019A (es) 2004-02-12
NZ529187A (en) 2005-10-28
EP1392318A1 (en) 2004-03-03
DE60218451T2 (de) 2007-11-08
AR100696A2 (es) 2016-10-26
EP1392318B1 (en) 2007-02-28
CA2444103C (en) 2010-06-08
CN1522147A (zh) 2004-08-18
DE60218451D1 (de) 2007-04-12
JP2004527567A (ja) 2004-09-09
CN1522147B (zh) 2010-05-12

Similar Documents

Publication Publication Date Title
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
UY26130A1 (es) Compuestos para tratar la obesidad
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
BRPI0520588B8 (pt) uso de composições farmacêuticas para o tratamento de doenças do ouvido interno
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BR0113184A (pt) Implante artificial e processo para produzir o mesmo
WO2008070670A3 (en) Enhanced immediate release formulations of topiramate
AR109263A2 (es) Composición que comprende moxidectina
ATE537819T1 (de) Nutrazeutische zusammensetzungen zur behandlung von muskelschwund
BR0315580A (pt) Derivados de metileno uréia
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0012696A (pt) Composição oftálmica
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
BR0210238A (pt) Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
PT1893237E (pt) Composição farmacêutica compreendendo um elastómero organopolissiloxano e um princípio activo solubilizado
WO2006113718A3 (en) Compositions for the treatment of neoplasms
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
BRPI0414822A (pt) método de inibir a produção de lipoproteìna remanescente
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0314419A (pt) Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o
BR0316775A (pt) Novos análogos de benzopirano e seu uso para o tratamento de glaucoma

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870220088950 DE 28/09/2022, EM VIRTUDE DO DISPOSTO NO ARTIGO 219 INCISO II DA LPI NO 9.279/96, UMA VEZ QUE NAO TEM FUNDAMENTACAO LEGAL.